文献速递外周动脉疾病

三种大隐静脉构型用于慢性肢体威胁性缺血的长期结局:VQI-Medicare关联数据库分析

Long-term outcomes of reversed, in situ, and nonreversed great saphenous vein conduits for chronic limb-threatening ischemia: An analysis of the Vascular Quality Initiative-Medicare-linked database.
PubMed 文献 · J Vasc Surg · 2026-08-11

基于VQI-Medicare关联数据库2011-2019年因闭塞性疾病行下肢旁路术的慢性肢体威胁性缺血患者,比较单段大隐静脉的三种构型(反转、原位、非反转)。5年无截肢生存率三组无显著差异;非反转构型相比原位构型5年死亡风险和大截肢/死亡风险更低,但主要反映患者选择差异。三种构型均为可接受的持久选择。

要点

  • 反转、原位、非反转三种大隐静脉构型的5年无截肢生存率无显著差异。
  • 非反转构型相比原位构型5年死亡风险及大截肢/死亡风险更低,但可能反映患者选择差异。
  • 三种构型与再干预风险无关,选择可依据术者偏好、血管可用性和患者解剖。

核心结论

  • 三种大隐静脉构型用于下肢旁路术的长期肢体相关结局基本相当。
  • 非反转构型相比原位构型5年死亡和大截肢/死亡风险更低,但差异主要源于死亡率,可能反映患者选择差异。
  • 三种构型均为可接受且持久的下肢旁路术选择。

研究设计与样本

  • 回顾性队列研究,查询Vascular Quality Initiative-Medicare关联数据库。
  • 纳入2011-2019年因闭塞性疾病行下肢旁路术的慢性肢体威胁性缺血患者,均使用单段大隐静脉。
  • 反转组N=3003(53.0%),原位组N=1344(23.7%),非反转组N=1322(23.3%)。
  • 主要结局为无截肢生存,次要结局包括总生存、保肢和免于再干预,分析1年和5年结局。
  • 采用Kaplan-Meier生存估计和Cox回归分析。

主要发现

  • 5年无截肢生存率在反转、原位、非反转组分别为39.8%、39.5%、42.4%(P = .126)。
  • 1年大截肢/死亡风险:原位组 vs 反转组 aHR 0.96(95%CI 0.83-1.13,P = .652);非反转组 vs 反转组 aHR 0.94(95%CI 0.81-1.08,P = .375)。
  • 5年大截肢/死亡风险:原位组 vs 反转组 aHR 1.06(95%CI 0.96-1.17,P = .255);非反转组 vs 反转组 aHR 0.93(95%CI 0.84-1.02,P = .129)。
  • 5年非反转组 vs 原位组:死亡 aHR 0.82(95%CI 0.73-0.93,P = .002),大截肢/死亡 aHR 0.87(95%CI 0.78-0.97,P = .016)。
  • 大隐静脉构型与再干预风险无关。

临床怎么用

  • 三种大隐静脉构型均可作为下肢旁路术的持久选择。
  • 构型选择可依据术者偏好、血管可用性和患者解剖。
  • 非反转构型5年死亡风险较低,但需考虑患者选择偏倚,不应据此推断因果。

局限性

  • 回顾性数据库研究,可能存在未测量混杂和患者选择偏倚。
  • 非反转构型与原位构型的生存差异主要源于死亡率,可能反映选择差异而非构型本身效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-segment great saphenous vein (GSV) grafts are the conduits of choice for infrainguinal bypass (IIB) performed for chronic limb-threatening ischemia. GSV has been used in three configurations: reversed, in situ, and nonreversed. In this large multi-institutional study, we aimed to compare the outcomes of IIB performed utilizing different GSV configurations in a real-world experience. METHODS: We queried the Vascular Quality Initiative-Medicare-linked database for all IIB procedures performed for chronic limb-threatening ischemia due to occlusive disease between 2011 and 2019. All bypass procedures were performed with single-segment GSV. The primary outcome was amputation-free survival. The secondary outcomes included overall survival, limb salvage, and freedom from reintervention. Limb salvage was defined as freedom from major amputation. All the outcomes were analyzed at 1 and 5 years. Kaplan-Meier survival estimates and Cox regression were used for analyses. RESULTS: This study included three cohorts of IIB, namely reversed (N = 3003, 53.0%), in situ (N = 1344, 23.7%), and nonreversed (N = 1322, 23.3%) GSV configurations. The 5-year amputation-free survival rates were 39.8%, 39.5%, and 42.4% in the reversed, in situ, and nonreversed cohorts, respectively (P = .126). After adjustment for potential confounders, the analysis revealed that the in situ and nonreversed configurations were not associated with increased hazard of major amputation/death at 1 year compared with the reversed configuration (adjusted hazard ratio [aHR], 0.96; 95% confidence interval [CI], 0.83-1.13; P = .652 and aHR, 0.94; 95% CI, 0.81-1.08; P = .375, respectively). Additionally, the in situ and nonreversed configurations were not associated with increased hazards of major amputation/death at 5 years compared with the reversed configuration (aHR, 1.06; 95% CI, 0.96-1.17; P = .255 and aHR, 0.93; 95% CI, 0.84-1.02; P = .129, respectively). The nonreversed configuration was associated with decreased hazards of death (aHR, 0.82; 95% CI, 0.73-0.93; P = .002) and major amputation/death (aHR, 0.87; 95% CI, 0.78-0.97; P = .016) at 5 years compared with the in situ configuration. GSV configurations were not associated with reintervention. CONCLUSIONS: In this large multi-institutional study comparing three GSV configurations for lower extremity bypass, long-term limb-related outcomes were mainly comparable across the configurations. Although the nonreversed configuration was associated with lower hazards of death and major amputation/death at 5 years compared with the in situ configuration, this difference was primarily due to mortality and may reflect differences in patient selection. Overall, all three GSV configurations represent acceptable and durable options for IIB, with conduit selection guided by surgeon preference, conduit availability, and patient anatomy.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rahgozar S, Zarrintan S, Hamouda M, et al. Long-term outcomes of reversed, in situ, and nonreversed great saphenous vein conduits for chronic limb-threatening ischemia: An analysis of the Vascular Quality Initiative-Medicare-linked database. J Vasc Surg. 2026. PMID: 42580534. doi:10.1016/j.jvs.2026.07.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。